It seems preferable to search for new agents that will improve insulin sensitivity in the pathway, leading to suppression of hepatic gluconeogenesis, as well as agents able to enhance glucose uptake in order to decrease the hyperglycaemia (Brown and Goldstein, 2008). Here, INS is linked to Hyperglycemia.